Department of Internal Medicine

Hematology, Oncology and Blood &
Marrow Transplantation Faculty

Roger D. Gingrich, M.D., Ph.D.
Professor
Director, Adult Blood & Marrow Transplantation Program
Associate Director for Clinical Services, Holden Comprehensive Cancer Center
Director, Cancer Center Protocol Review Committee

Dr. Gingrich's research interests focus on clinical studies on bone marrow transplantation. Two specific areas of his research involve protocols that tailor for each patient the balance of the risk and benefit of graft versus host disease in patients receiving allogeneic BMT; and studies of intensive salvage therapy combined with autologous hemopoietic stem cell transplantation for patients with breast cancer.

Honors, Awards, and Organizations

Alison Eberlein Award
Alpha Omega Alpha
American Association for the Advancement of Science
Diplomate, American Board of Internal Medicine American Council on Transplantation
American Society for Transplant Physicians
American Society for Hematology
Hartford Fellowship
International Society of Experimental Hematology
Mosby Award

Roger Gingrich, M.D., Ph.D.

Medical School:
Cornell University

Graduate School:
Cell Physiology,
Sir William Dunn School of Pathology, Oxford, England

Residency:
The University of Iowa

Fellowship:
The University of Iowa

Recent Publications

deMagalhaes-Silverman, M., Lee, C.K., Hohl, R., Schlueter, A., Ritchie, J., Gingrich, R. Allergenic Transplantation of CD34+ Selected Peripheral Blood Progenitors Cells from HLA Matched Identical Siblings Followed by Pre-Emptive T-Cell Add-Back: A Feasibility Study. Stem Cell and Cellular Therapy. 1, 21-28, 2003.
Lee, C.K., deMagalhaes-Silverman, M., Hohl, R.J., Hayashi, M., Buatti, J., Wen, B.C., Schlueter, A., Strauss, R., Gingrich, R.D. Donor T lymphocyte infusion for unrelated allergenic bone marrow transplantation with CD3+ T-cell depleted graft, accepted, 2002.
Lee, C.K., deMagalhaes-Silverman, M., Hayashi, M., Schlueter, A., Strauss, R.G., Hohl, R.J., Gingrich, R.D. High-dose chemotherapy A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation. Bone Marrow Transplantation, 29, 647-652, 2002.

Links of Interest

Back to Hematology-Oncology Faculty List